Atlas company financials

Medpace Holdings, Inc.

Standardized 11-year financial series for Medpace Holdings, Inc., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001668397FY2015 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$2.5B

Adjusted EBITDA

—

Net result

$451.1M

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$706.6M

TTM revenue

$2.5B

TTM free cash flow

—

Latest quarter net result

$123.9M

Quarterly coverage: 32 periods · latest quarter FY2026-Q1 · TTM revenue growth 22.4%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · medpace-holdings-inc-fy2015 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2017-02-28 · Retrieved: 2026-04-26T11:47:08.004440+00:00
SEC EDGAR companyfacts
primary · medpace-holdings-inc-fy2017 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2018-02-27 · Retrieved: 2026-04-26T11:47:08.004440+00:00
SEC EDGAR companyfacts
primary · medpace-holdings-inc-fy2018 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2019-02-26 · Retrieved: 2026-04-26T11:47:08.004440+00:00
SEC EDGAR companyfacts
primary · medpace-holdings-inc-fy2019 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2020-02-25 · Retrieved: 2026-04-26T11:47:08.004440+00:00
SEC EDGAR companyfacts
primary · medpace-holdings-inc-fy2020 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2021-02-16 · Retrieved: 2026-04-26T11:47:08.004440+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2015	359M	—	21M	-9M	86M	-6M	363M	comparative annual fact carried from later 10k · missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development
FY2016	422M	—	52M	13M	92M	-14M	127M	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development
FY2017	436M	—	65M	39M	97M	-12M	195M	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development
FY2018	705M	—	101M	73M	157M	-16M	56M	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development
FY2019	861M	—	127M	100M	202M	-18M	-132M	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development
FY2020	926M	—	167M	145M	259M	-31M	—	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing net financial debt · missing research and development
FY2021	1B	—	199M	182M	263M	-28M	-461M	missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing inventory · missing research and development

Filing provenance